Graf Acquisition Corp. IV filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, WithumSmith+Brown, PC , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.29 USD | -3.73% | -18.29% | -84.46% |
1st Jan change | Capi. | |
---|---|---|
-84.46% | 30.56M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- NKGN Stock
- NKGN Stock
- News NKGen Biotech, Inc.
- Graf Acquisition Corp. IV Auditor Raises 'Going Concern' Doubt